Analysts Estimate Acceleron Pharma (XLRN) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 07/29/21
Acceleron to Host Virtual Research and Development (R&D) Day on June 22, 2021Business Wire • 06/08/21
Ongoing Treatment With Acceleron's Sotatercept Continue To Show Benefit In PAH PatientsBenzinga • 05/19/21
Acceleron Presents Preliminary Data from the SPECTRA Phase 2 Trial of Sotatercept in Pulmonary Arterial Hypertension (PAH) at the American Thoracic Society 2021 International ConferenceBusiness Wire • 05/19/21
Acceleron Presents Interim Results from the Open-label Extension of the PULSAR Phase 2 Trial of Sotatercept in Patients with Pulmonary Arterial Hypertension (PAH) at the American Thoracic Society 2021 International ConferenceBusiness Wire • 05/19/21
Acceleron Announces Presentations on REBLOZYL® (luspatercept-aamt) at the 2021 European Hematology Association Virtual CongressBusiness Wire • 05/12/21
Acceleron to Host Conference Call and Webcast to Review Clinical Trial Updates, Preclinical Presentations on Sotatercept in Pulmonary Arterial Hypertension (PAH) Presented at the American Thoracic Society (ATS) 2021 International ConferenceBusiness Wire • 05/11/21
Acceleron Pharma Inc. (XLRN) CEO Habib Dable on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/09/21
Acceleron Pharma (XLRN) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/06/21
Will Acceleron Pharma (XLRN) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 04/29/21
Acceleron Announces Clinical Trial Updates, Preclinical Presentations on Sotatercept in Pulmonary Arterial Hypertension (PAH) at the American Thoracic Society (ATS) 2021 International ConferenceBusiness Wire • 04/05/21
New England Journal of Medicine Publishes Results of the PULSAR Phase 2 Trial of Sotatercept in Patients with Pulmonary Arterial HypertensionBusiness Wire • 04/01/21
Acceleron Pharma Inc. (XLRN) CEO Habib Dable on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/26/21